New Service: Alicanto for Antibody Discovery from Human Serum
We recently had the pleasure of attending the PEGS Boston Conference. We had the privilege of showcasing our work through a poster presentation, a talk, and an exhibit booth. Among the highlights were engaging with experts, exchanging ideas, and strengthening our network within the community. But perhaps the most important was launching our newest service: Alicanto For Antibody Discovery From Human Serum. It was truly a great time for Abterra Biosciences!
Watch our CEO, Dr. Natalie Castellana’s presentation on Discovering SARS-CoV2 Antibodies From Patient Serum With Alicanto below. This was our first antibody discovery project utilizing human serum!
Click below to watch the presentation.
Related Posts
Advantages of High-Throughput Hybridoma Sequencing with NGS
High-throughput hybridoma sequencing gives more information at an earlier stage. Our Reptor platform has sequenced thousands of clones.
Why Sequence My Antibody Protein?
Why should I sequence my antibody protein? Abterra Bio gives the top reasons to sequence your antibody protein.
Case Study: Alicanto Discovers High Affinity Rabbit Antibodies to Detect Neurofibromin
Infixion Bioscience and Abterra Bio set out to develop high affinity neurofibromin antibody reagents to detect NF1.
Get In Touch